The Effect of Vegetable Oil on Cognitive Functions of MCI Patients

NCT ID: NCT03727386

Last Updated: 2021-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-19

Study Completion Date

2021-05-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study explores the feasibility of applying an intervention using vegetable oils (coconut and sunflower oils) on individuals diagnosed with Mild Cognitive Impairment. Participants will be divided into two groups and will either receive 30 ml of coconut or sunflower oil to be consumed daily for six months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research has shown that some forms of dementia associated to ageing can often be linked to low levels of sugar in the brain. Which may cause damage to the brain nerve cells. The main source of fuel for the brain comes from sugar in the form of glucose. Providing an additional source of fuel to brain cells may reduce the damage, potentially preventing further decline of dementia in individuals with Mild Cognitive Impairment (MCI).

This study explores the possibility of using vegetable oils (coconut and sunflower oils) as an additional source of energy to individuals diagnosed with Mild Cognitive Impairment. The researchers will use different tests to evaluate if the study could be done. Participants will be divided into two groups and will either receive 30 ml of coconut or sunflower oil to be consumed daily for six months. The researchers will visit participants in their houses over three times during the study to collect the data.

During each visit, the researcher will conduct blood test in which blood will be collected by pricking the finger of participants to check their blood ketone levels. Paper pencil and/or computer tasks will be completed to measure the cognitive abilities (e.g. attention, orientation and learning) of participants. Participants will also be asked to complete a food diary in which they will provide details of their diet and eating habits. Moreover, they will be asked to provide feedback on the study by answering a set of questions either during an interview or by completing a feedback form. The information collected during these visits will be used to evaluate the study.

Results from this study would help determine whether such an intervention can be undertaken in adults with MCI. The study will provide information related to the practicality of using vegetable oils on adults with MCI. This would provide the evidence to develop a larger study that would allow us to systematically evaluate the effect of vegetable oils on MCI. Which would further enable us to develop an intervention that might possibly improve the brain functions of adults with MCI and maintain their quality of life for longer by delaying the development of dementia and reducing the progression from MCI to AD (Alzheimer's disease) in adults.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Ketosis Cognitive Impairments, Mild

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study will be a pilot study with an internal feasibility study that aims at evaluating the acceptance and adherence of participants to the intervention. Participants will be randomized into an intervention (coconut oil) and control group (sunflower oil) using an online randomisation software; Sealed envelope.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coconut oil

A dietary intervention that relies on the administration of 30 ml of extra virgin coconut oil per day for six months will be utilized in this study. Coconut oil administered will replace the cooking/vegetable oil usually used by the participants. .

Group Type EXPERIMENTAL

Coconut oil

Intervention Type OTHER

Participants will receive 30 ml of virgin coconut oil to replace their normal oil intake for a period of 6 months.

Sunflower oil

A dietary intervention that relies on the administration of 30 ml of sunflower oil per day for 6 months will be utilized in this study. The oil administered will replace the cooking/vegetable oil usually used by the participants.

Group Type PLACEBO_COMPARATOR

Sunflower oil

Intervention Type OTHER

Participants will receive 30 ml of sunflower oil to replace their normal oil intake for a period of 6 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coconut oil

Participants will receive 30 ml of virgin coconut oil to replace their normal oil intake for a period of 6 months.

Intervention Type OTHER

Sunflower oil

Participants will receive 30 ml of sunflower oil to replace their normal oil intake for a period of 6 months.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

extra virgin coconut oil

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with confirmed MCI diagnosis
* Adults with Negative Apo E4 genotype

Exclusion Criteria

* Adults diagnosed with Alzheimer's Disease (AD)
* Adults with positive Apo E4 genotype
* Adults with confirmed diabetes (Type I, Type II) diagnosis
* Adults with a history of hyper-cholesterolemia (high cholesterol levels) or Dyslipidaemia
* Adults who are unable to understand written or verbal English
* Adults diagnosed with Neurological disorders (Parkinson, stroke…)
* Adults with post traumatic brain injury (tumour, brain surgery, injury…)
* Patients with major physical impairments (blind, deaf) or those who are unable to use their dominant hand.
* Adults with coconut allergy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dorset HealthCare University NHS Foundation Trust

OTHER

Sponsor Role collaborator

Bournemouth University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raysa EL Zein, MSc

Role: PRINCIPAL_INVESTIGATOR

Student

Jane Murphy Professor, PhD

Role: STUDY_DIRECTOR

Professor of Nutrition

Peter Thomas Professor, PhD

Role: STUDY_DIRECTOR

Professor of Health Care Stats & Epidemiology

Shanti Shanker Doctor, PhD

Role: STUDY_DIRECTOR

Lucturer of Psychology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bournemouth University

Bournemouth, Dorset, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1718/IRASREZ/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Flax Muffins and Cholesterol Lowering
NCT01821131 ACTIVE_NOT_RECRUITING NA